NCT02538367View on ClinicalTrials.gov

Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Functional Constipation
Interventions
DRUG

YH12852 IR 0.05mg

DRUG

YH12852 IR 0.1mg

DRUG

YH12852 IR 0.3mg

DRUG

YH12852 IR 0.5mg

DRUG

YH12852 IR 1mg

DRUG

YH12852 IR 2mg

DRUG

YH12852 IR 3mg

DRUG

YH12852 DR1 0.5mg

DRUG

YH12852 DR1 1mg

DRUG

YH12852 DR1 2mg

DRUG

YH12852 DR1 4mg

DRUG

YH12852 DR2 8mg

DRUG

Prucalopride 2mg

DRUG

Placebo

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02538367 - Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation | Biotech Hunter | Biotech Hunter